This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Natalia V Pigareva: Innovator in Immunomodulatory Compounds
Introduction
Natalia V Pigareva is a prominent inventor based in St. Petersburg, Russia. She has made significant contributions to the field of immunology through her innovative research and development of synthetic immunomodulatory molecules. Her work has the potential to impact various therapeutic applications.
Latest Patents
Natalia holds a patent for a new class of synthetic immunomodulatory compounds that contain a .gamma.-L-glutamyl moiety at the amino terminus. This patent, which includes the compound BESTIM, showcases her expertise in creating molecules that can modulate immune responses. The patent details various compounds, including .gamma.-L-glutamyl-L-tryptophan and its derivatives, which are designed to enhance immunological functions.
Career Highlights
Throughout her career, Natalia has focused on the development of immunomodulators that can be utilized in medical treatments. Her innovative approach has led to the creation of compounds that are not only effective but also have a unique chemical structure that sets them apart from existing therapies. With 1 patent to her name, she continues to push the boundaries of scientific research.
Collaborations
Natalia has collaborated with notable colleagues in her field, including Natalia M Kalinina and Vladimir M Shpen. These partnerships have fostered a collaborative environment that enhances the research and development of new immunomodulatory compounds.
Conclusion
In summary, Natalia V Pigareva is a trailblazer in the field of immunology, with her innovative patents paving the way for future advancements in immunomodulatory therapies. Her contributions are invaluable to the scientific community and hold promise for improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile